HMGB1-Mediated Early Loss of Transplanted Islets Is Prevented by Anti–IL-6R Antibody in Mice
暂无分享,去创建一个
T. Itoh | Y. Yasunami | J. Ono | T. Mera | S. Kodama | H. Nishinakamura | D. Kojima | T. Nitta | Hitomi Nishinakamura
[1] A. Dennison,et al. Evation of High-Mobility Group Box 1 after Clinical Autologous Islet Transplantation and Its Inverse Correlation with Outcomes , 2014, Cell transplantation.
[2] T. Itoh,et al. Inhibitory Effect of Thrombomodulin on HMGB1-Stimulated IFN-γ Production of Hepatic NKT and Gr-1+ Cells, Facilitating to Prevent Early Loss of Transplanted Islets in the Liver of Mice: 1512 , 2012 .
[3] E. Bonifacio,et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. , 2012, The Journal of clinical investigation.
[4] A. Shapiro,et al. Update on islet transplantation. , 2012, Cold Spring Harbor perspectives in medicine.
[5] B. Hering,et al. Potent Induction Immunotherapy Promotes Long‐Term Insulin Independence After Islet Transplantation in Type 1 Diabetes , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] T. Itoh,et al. Prevention of High-Mobility Group Box 1-Mediated Early Loss of Transplanted Mouse Islets in the Liver by Antithrombin III , 2012, Transplantation.
[7] J. Singh,et al. Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor. , 2012, Clinical therapeutics.
[8] Hiroshi Yamamoto,et al. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. , 2010, The Journal of clinical investigation.
[9] Y. Yamashita,et al. Prevention of Early Loss of Transplanted Islets in the Liver of Mice by Adenosine , 2009, Transplantation.
[10] R. Larsson,et al. Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet Transplantation , 2007, Diabetes.
[11] M. Taniguchi,et al. Successful Islet Transplantation to Two Recipients From a Single Donor by Targeting Proinflammatory Cytokines in Mice , 2007, Transplantation.
[12] T. Kishimoto,et al. Interleukin 6: from bench to bedside , 2006, Nature Clinical Practice Rheumatology.
[13] L. Staudt,et al. Clinical Trials and Observations , 2007 .
[14] O. Ohara,et al. Vα14 NK T cell–triggered IFN-γ production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets , 2005, The Journal of experimental medicine.
[15] K. Ekdahl,et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation , 2002, The Lancet.
[16] T. Abo,et al. Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 re , 1997, Transplantation.
[17] S. Akira,et al. Interleukin-6 family of cytokines and gp130. , 1995, Blood.
[18] R. Madhok,et al. Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. , 1993, Annals of the rheumatic diseases.
[19] P. Morris,et al. ISOLATION OF RAT PANCREATIC ISLETS BY DUCTAL INJECTION OF COLLAGENASE1 , 1986, Transplantation.
[20] J. Ono,et al. Simple method for the collection of pancreatic islets by the use of Ficoll-Conray gradient. , 1979, Endocrinologia japonica.
[21] P. Lacy,et al. Transplantation of Isolated Pancreatic Islets into the Portal Vein of Diabetic Rats , 1973, Nature.
[22] M. Taniguchi,et al. Methods for detection, isolation and culture of mouse and human invariant NKT cells , 2007, Nature Protocols.
[23] Ames,et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .
[24] Y. Shima,et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. , 2000, Blood.
[25] T. Kishimoto,et al. Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.
[26] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. , 1989, Blood.